Losartan Alleviates the Side Effects and Maintains the Anticancer Activity of Axitinib

Axitinib is one of the most potent inhibitors of the vascular endothelial growth factor (VEGF) receptor and shows strong antitumor activity toward various malignant tumors. However, its severe side effects affect the quality of life and prognosis of patients. Losartan, which functions as a typical a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Ying, Saxu, Rengui, Ridwan, Kadir Ahmad, Yao, Jiaping, Chen, Xiaoxuan, Xu, Xueping, Zheng, Weida, Yu, Peng, Teng, Yuou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101101/
https://www.ncbi.nlm.nih.gov/pubmed/35566115
http://dx.doi.org/10.3390/molecules27092764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101101/
https://www.ncbi.nlm.nih.gov/pubmed/35566115
http://dx.doi.org/10.3390/molecules27092764

Ejemplares similares